KA87.6

ICD-11 MMS 2026-01

Neonatal hyperbilirubinaemia from other or unspecified hepatocellular damage

Coding note from above levels

Conditions arising in the perinatal period, even though death or morbidity occurs later, should, as far as possible, be coded to chapter 19, which takes precedence over chapters containing codes for diseases by their anatomical site. For children less than 28 days old, assume that a reported condition developed in the perinatal period, unless the duration is stated and the onset was after the first completed week of life.

Index terms

  • Neonatal hyperbilirubinaemia from other or unspecified hepatocellular damage
  • Neonatal hyperbilirubinaemia following hepatocellular damage
  • Neonatal jaundice from other and unspecified hepatocellular damage
Show allHide
  • Fetal or neonatal idiopathic hepatitis
  • fetal or neonatal hepatitis
  • hepatitis of fetus or newborn
  • neonatal hepatitis
  • Neonatal giant cell hepatitis

Exclusions from above levels

  • KA84.0 – jaundice due to isoimmunization
  • 3A10 – Hereditary haemolytic anaemia
  • 5C58.00 – Crigler-Najjar syndrome
Show allHide
  • 5C58.01 – Gilbert syndrome
  • 5C58.02 – Dubin-Johnson syndrome
  • LB20.22 – Congenital stenosis or stricture of bile ducts
  • 01 – Certain infectious or parasitic diseases - acquired after birth
  • 02 – Neoplasms
  • 05 – Endocrine, nutritional or metabolic diseases
  • 08 – Certain congenital diseases of the nervous system
  • 20 – Congenital malformations, deformations and chromosomal abnormalities
  • 22 – Injury, poisoning or certain other consequences of external causes
  • 4A01.03 – Transient hypogammaglobulinaemia of infancy
  • 9B71.3 – Retinopathy of prematurity
  • BC43 – congenital cardiomyopathy
  • DA93.0 – Paralytic ileus
  • EA50.Z – Pemphigus neonatorum
  • EH40.00 – Cradle cap
  • http://id.who.int/icd/entity/588616678 – Gastroenteritis or colitis of infectious origin
  • http://id.who.int/icd/entity/609214049 – Congenital gonococcal infection

Sibling codes

  • KA87.0 – Neonatal hyperbilirubinaemia due to swallowed maternal blood
  • KA87.1 – Neonatal hyperbilirubinaemia due to enzymatic defect in bilirubin degradation
  • KA87.2 – Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation
  • KA87.3 – Neonatal hyperbilirubinaemia due to total parenteral nutrition
  • KA87.4 – Neonatal hyperbilirubinaemia due to drugs or toxins transmitted from mother
  • KA87.5 – Neonatal hyperbilirubinaemia due to drugs or toxins given to newborn
  • KA87.Y – Other specified neonatal hyperbilirubinaemia
  • KA87.Z – Neonatal hyperbilirubinaemia, unspecified

Foundation entity

Neonatal hyperbilirubinaemia from other or unspecified hepatocellular damage – http://id.who.int/icd/entity/1755224858

Part of: KA87: Neonatal hyperbilirubinaemia › 19: Certain conditions originating in the perinatal period